Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'QUINUPRISTIN/DALFOPRISTIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 112 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Bonfiglio, G; Furneri, PM
      Novel streptogramin antibiotics

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    2. Pantosti, A; D'Ambrosio, F; Bordi, E; d'Abusco, AS; Del Grosso, M
      Activity of quinupristin-dalfopristin in invasive isolates of Streptococcus pneumoniae from Italy

      CLINICAL MICROBIOLOGY AND INFECTION
    3. Ricaurte, JC; Boucher, HW; Turett, GS; Moellering, RC; LaBombardi, VJ; Kislak, JW
      Chloramphenicol treatment for vancomycin-resistant Enterococcus faecium bacteremia

      CLINICAL MICROBIOLOGY AND INFECTION
    4. Schulin, T; Voss, A
      Coagulase-negative staphylococci as a cause of infections related to intravascular prosthetic devices: limitations of present therapy

      CLINICAL MICROBIOLOGY AND INFECTION
    5. Marchese, A; Schito, GC
      The oxazolidinones as a new family of antimicrobial agent

      CLINICAL MICROBIOLOGY AND INFECTION
    6. Jones, RN; Biedenbach, DJ; Johnson, DM; Pfaller, MA
      In vitro evaluation of BI 397, a novel glycopeptide antimicrobial agent

      JOURNAL OF CHEMOTHERAPY
    7. Bain, KT; Wittbrodt, ET
      Linezolid for the treatment of resistant gram-positive cocci

      ANNALS OF PHARMACOTHERAPY
    8. Zeana, C; Kubin, CJ; Della-Latta, P; Hammer, SM
      Vancomycin-resistant Enterococcus faecium meningitis successfully managed with linezolid: Case report and review of the literature

      CLINICAL INFECTIOUS DISEASES
    9. Nichols, RL; Florman, S
      Clinical presentations of soft-tissue infections and surgical site infections

      CLINICAL INFECTIOUS DISEASES
    10. Babcock, HM; Ritchie, DJ; Christiansen, E; Starlin, R; Little, R; Stanley, S
      Successful treatment of vancomycin-resistant Enterococcus endocarditis with oral linezolid

      CLINICAL INFECTIOUS DISEASES
    11. Olsen, KM; Rebuck, JA; Rupp, ME
      Arthralgias and myalgias related to quinupristin-dalfopristin administration

      CLINICAL INFECTIOUS DISEASES
    12. Low, DE; Keller, N; Barth, A; Jones, RN
      Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999

      CLINICAL INFECTIOUS DISEASES
    13. McKinnon, PS; Tam, VH
      New antibiotics for infections caused by resistant organisms

      SUPPORTIVE CARE IN CANCER
    14. Ioannidou, S; Tassios, PT; Kotsovili-Tseleni, A; Foustoukou, M; Legakis, NJ; Vatopoulos, A
      Antibiotic resistance rates and macrolide resistance phenotypes of viridans group streptococci from the oropharynx of healthy Greek children

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    15. Etienne, J
      Epidemiology context: antimicrobial effect of Synercid (R)

      PRESSE MEDICALE
    16. Fantin, B
      Synercid (R) and other anti-Gram positive agents

      PRESSE MEDICALE
    17. Potel, G
      Contribution of Synercid (R) in clinical practice

      PRESSE MEDICALE
    18. Hallgren, A; Abednazari, H; Ekdahl, C; Hanberger, H; Nilsson, M; Samuelsson, A; Svensson, E; Nilsson, LE
      Antimicrobial susceptibility patterns of enterococci in intensive care units in Sweden evaluated by different MIC breakpoint systems

      Journal of antimicrobial chemotherapy
    19. Fornas, FL; Garcia, FM; Salmeron, JP; Conesa, DR; Sanchez, RC; Alberola, AG; Gomez, JR; Gomez, JG; Chavarri, MV
      Comparative study of treatment with penicillin, ceftriaxone, trovafloxacin, quinupristin-dalfopristin and vancomycin in experimental endocarditis dueto penicillin- and ceftriaxone-resistant Streptococcus pneumoniae

      Journal of antimicrobial chemotherapy
    20. Rehm, SJ; Graham, DR; Srinath, L; Prokocimer, P; Richard, MP; Talbot, GH
      Successful administration of quinupristin/dalfopristin in the outpatient setting

      Journal of antimicrobial chemotherapy
    21. Jones, RN; Hare, RS; Sabatelli, FJ
      In vitro Gram-positive antimicrobial activity of evernimicin (SCH 27899), a novel oligosaccharide, compared with other antimicrobials: a multicentre international trial

      Journal of antimicrobial chemotherapy
    22. Linden, PK; Bompart, F; Gray, S; Talbot, GH
      Hyperbilirubinemia during quinupristin-dalfopristin therapy in liver transplant recipients: Correlation with available liver biopsy results

      PHARMACOTHERAPY
    23. Garey, KW; Tesoro, E; Muggia, V; Pasquier, O; Rodvold, KA
      Cerebrospinal fluid concentrations of quinupristin-dalfopristin in a patient with vancomycin-resistant Enterococcus faecalis ventriculitis

      PHARMACOTHERAPY
    24. Gunderson, BW; Ross, GH; Ibrahim, KH; Rotschafer, JC
      What do we really know about antibiotic pharmacodynamics?

      PHARMACOTHERAPY
    25. Grau, S; Alvarez-Lerma, F; Marin, M; Gimeno, JL
      Problems and current solutions for the treatment of infections caused by gram-positive microorganisms

      ENFERMEDADES INFECCIOSAS Y MICROBIOLOGIA CLINICA
    26. Fung, HB; Kirschenbaum, HL; Ojofeitimi, BO
      Linezolid: An oxazolidinone antimicrobial agent

      CLINICAL THERAPEUTICS
    27. Allington, DR; Rivey, MP
      Quinupristin/dalfopristin: A therapeutic review

      CLINICAL THERAPEUTICS
    28. Diekema, DJ; Jones, RN
      Oxazolidinone antibiotics

      LANCET
    29. Reinert, RR; von Eiff, C; Kresken, M; Brauers, J; Hafner, D; Al-Lahham, A; Schorn, H; Lutticken, R; Peters, G
      Nationwide German multicenter study on the prevalence of antibiotic resistance in streptococcal blood isolates from neutropenic patients and comparative in vitro activities of quinupristin-dalfopristin and eight ether antimicrobials

      JOURNAL OF CLINICAL MICROBIOLOGY
    30. Chevalier, P; Rey, J; Pasquier, O; Rouzier-Panis, R; Harding, N; Montay, G
      Multiple-dose pharmacokinetics and safety of two regimens of quinupristin/dalfopristin (Synercid (R)) in healthy volunteers

      JOURNAL OF CLINICAL PHARMACOLOGY
    31. Bodi, M; Ardanuy, C; Rello, J
      Impact of Gram-positive resistance on outcome of nosocomial pneumonia

      CRITICAL CARE MEDICINE
    32. Siami, G; Christou, N; Eiseman, I; Tack, KJ
      Clinafloxacin versus piperacillin-tazobactam in treatment of patients withsevere skin and soft tissue infections

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    33. Patel, R; Rouse, MS; Piper, KE; Steckelberg, JM
      Linezolid therapy of vancomycin-resistant Enterococcus faecium experimental endocarditis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    34. Soltani, H; Beighton, D; Philpott-Howard, J; Woodford, N
      Identification of vat(E-3), a novel gene encoding resistance to quinupristin-dalfopristin in a strain of Enterococcus faecium from a hospital patientin the United Kingdom

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    35. Raad, I; Hachem, R; Hanna, H; Girgawy, E; Rolston, K; Whimbey, E; Husni, R; Bodey, G
      Treatment of vancomycin-resistant enterococcal infections in the immunocompromised host: Quinupristin-dalfopristin in combination with minocycline

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    36. Walzer, PD; Ashbaugh, A; Collins, M; Cushion, MT
      In vitro and in vivo effects of quinupristin-dalfopristin against Pneumocystis carinii

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    37. Hussain, Z; Shaikh, A; Peloquin, CA; Ericsson, CD
      Successful treatment of vancomycin-resistant enterococcus faecium meningitis with linezolid: Case report and literature review

      SCANDINAVIAN JOURNAL OF INFECTIOUS DISEASES
    38. Aubel, D; Morris, R; Lennon, B; Rimann, M; Kaufmann, H; Folcher, M; Bailey, JE; Thompson, CJ; Fussenegger, M
      Design of a novel mammalian screening system for the detection of bioavailable, non-cytotoxic streptogramin antibiotics

      JOURNAL OF ANTIBIOTICS
    39. Perry, CM; Jarvis, B
      Linezolid - A review of its use in the management of serious Gram-positiveinfections

      DRUGS
    40. Konstantinov, IE; Zehr, KJ
      Aortic root replacement in a patient with vancomycin-resistant Enterococcus faecium endocarditis and leukemia

      CHEST
    41. Ling, TKW; Fung, KSC; Cheng, AFB
      In vitro activity and post-antibiotic effect of quinupristin/dalfopristin (Synercid)

      CHEMOTHERAPY
    42. Manzella, JP
      Quinupristin-dalfopristin: A new antibiotic for severe gram-positive infections

      AMERICAN FAMILY PHYSICIAN
    43. Bush, K; Macielag, M
      New approaches in the treatment of bacterial infections

      CURRENT OPINION IN CHEMICAL BIOLOGY
    44. Carfagna, P; Tarasi, A; Cassone, M; Del Grosso, MF; Bianco, G; Venditti, M
      Prosthetic biologic valve endocarditis caused by a vancomycin-resistant (vanA) Enterococcus faecalis: Case report

      JOURNAL OF CHEMOTHERAPY
    45. Fussenegger, M; Morris, RP; Fux, C; Rimann, M; von Stockar, B; Thompson, CJ; Bailey, JE
      Streptogramin-based gene regulation systems for mammalian cells

      NATURE BIOTECHNOLOGY

    46. Synercid: Quinupristin/dalfopristin in synergy

      FORMULARY
    47. Moellering, RC; Linden, PK; Reinhardt, J; Blumberg, EA; Bompart, F; Talbot, GH
      The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium (Reprinted from The Journal Antimicrobial Chemotherapy, vol 44, pg 251-261, 1999)

      FORMULARY
    48. McNeil, SA; Clark, NM; Chandrasekar, PH; Kauffman, CA
      Successful treatment of vancomycin-resistant Enterococcus faecium bacteremia with linezolid after failure of treatment with synercid (quinupristin/dalfopristin)

      CLINICAL INFECTIOUS DISEASES
    49. Chien, JW; Kucia, ML; Salata, RA
      Use of linezolid, an oxazolidinone, in the treatment of multidrug-resistant gram-positive bacterial infections

      CLINICAL INFECTIOUS DISEASES
    50. Patterson, JE
      New Gram-positive agents in nosocomial infection

      CURRENT OPINION IN INFECTIOUS DISEASES
    51. Marshall, SA; Kugler, KC; Jones, RN
      Evaluation of quinupristin/dalfopristin (Synercid (R)) and RPR 106 972 stability in susceptibility testing media

      INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
    52. Gray, JW; Darbyshire, PJ; Beath, SV; Kelly, D; Mann, JR
      Experience with quinupristin/dalfopristin in treating infections with vancomycin-resistant Enterococcus faecium in children

      PEDIATRIC INFECTIOUS DISEASE JOURNAL
    53. Walsh, TJ; Wayne, AS
      Management of infections in patients with acute leukemia - The article reviewed

      ONCOLOGY-NEW YORK
    54. Patel, R; Rouse, MS; Piper, KE; Steckelberg, JM
      In vitro activity of GAR-936 against vancomycin-resistant enterococci, methicillin-resistant Staphylococcus aureus and penicillin-resistant Streptococcus pneumoniae

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    55. Dowzicky, M; Talbot, GH; Feger, C; Prokocimer, P; Etienne, J; Leclercq, R
      Characterization of isolates associated with emerging resistance to quinupristin/dalfopristin (Synercid (R)) during a worldwide clinical program

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    56. Hwang, SH; Kim, MN; Pai, CH; Huh, DH; Shin, WS
      In vitro activities of quinupristin/dalfopristin and eight other antimicrobial agents against 360 clinical isolates from Korea

      YONSEI MEDICAL JOURNAL
    57. Carretto, E; Barbarini, D; Locatelli, F; Giraldi, E; Pellegrini, N; Perversi, L; Grossi, P; Marone, P; Bonetti, F
      Vancomycin-resistant Enterococcus faecium infection in three children given allogeneic hematopoietic stem cell transplantation: clinical and microbiological features

      HAEMATOLOGICA

    58. Quinupristin/dalfopristin - Synercid (R) - Streptogramin antibiotic

      DRUGS OF THE FUTURE
    59. Catalano, OA; Hahn, PF; Hooper, DC; Mueller, PR
      Efficacy of percutaneous abscess drainage in patients with vancomycin-resistant enterococci

      AMERICAN JOURNAL OF ROENTGENOLOGY
    60. Drew, RH; Perfect, JR; Srinath, L; Kurkimilis, E; Dowzicky, M; Talbot, GH
      Treatment of methicillin-resistant Staphylococcus aureus infections with quinupristin-dalfopristin in patients intolerant of or failing prior therapy

      Journal of antimicrobial chemotherapy
    61. Gander, S; Finch, R
      The effects of exposure at constant (1 h) or exponentially decreasing concentrations of quinupristin/dalfopristin on biofilms of Gram-positive bacteria

      Journal of antimicrobial chemotherapy
    62. Al-Nawas, B; Swantes, J; Shah, PM
      In vitro activity of LY333328, a new glycopeptide, against extracellular and intracellular vancomycin-resistant enterococci

      INFECTION
    63. Heer, C; Stuertz, K; Reinert, RR; Mader, M; Nau, R
      Release of teichoic and lipoteichoic acids from 30 different strains of Streptococcus pneumoniae during exposure to ceftriaxone, meropenem, quinupristin/dalfopristin, rifampicin and trovafloxacin

      INFECTION
    64. von Eiff, C; Reinert, RR; Kresken, M; Brauers, J; Hafner, D; Peters, G
      Nationwide German multicenter study on prevalence of antibiotic resistancein staphylococcal bloodstream isolates and comparative in vitro activitiesof quinupristin-dalfopristin

      JOURNAL OF CLINICAL MICROBIOLOGY
    65. Yamaguchi, T; Hirakata, Y; Izumikawa, K; Miyazaki, Y; Maesaki, S; Tomono, K; Yamada, Y; Kamihira, S; Kohno, S
      In vitro activity of telithromycin (HMR3647), a new ketolide, against clinical isolates of Mycoplasma pneumoniae in Japan

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    66. Soltani, M; Beighton, D; Philpott-Howard, J; Woodford, N
      Mechanisms of resistance to quinupristin-dalfopristin among isolates of Enterococcus faecium from animals, raw meat, and hospital patients in westernEurope

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    67. Rachid, S; Ohlsen, K; Witte, W; Hacker, J; Ziebuhr, W
      Effect of subinhibitory antibiotic concentrations on polysaccharide intercellular adhesin expression in biofilm-forming Staphylococcus epidermidis

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    68. Luh, KT; Hsueh, PR; Teng, LJ; Pan, HJ; Chen, YC; Lu, JJ; Wu, JJ; Ho, SW
      Quinupristin-dalfopristin resistance among gram-positive bacteria in Taiwan

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    69. Fuchs, PC; Barry, AL; Brown, SD
      Bactericidal activity of quinupristin-dalfopristin against Staphylococcus aureus: Clindamycin susceptibility as a surrogate indicator

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    70. Murray, BE
      Drug therapy: Vancomycin-resistant enterococcal infections.

      NEW ENGLAND JOURNAL OF MEDICINE
    71. Khan, AA; Slifer, TR; Araujo, FG; Remington, JS
      Effect of quinupristin/dalfopristin on production of cytokines by human monocytes

      JOURNAL OF INFECTIOUS DISEASES
    72. Elsner, HA; Sobottka, I; Feucht, HH; Claussen, M; Kaulfers, PM; Laufs, R; Mack, D
      In vitro susceptibilities of enterococcal blood culture isolates from the Hamburg area to ten antibiotics

      CHEMOTHERAPY
    73. Rubio, MC; Goni, P; Vergara, Y; Seral, C; Garcia, C; Gomez-Lus, P; Gomez-Lus, R
      Susceptibility of penicillin-resistant and penicillin-susceptible Streptococcus pneumoniae to newer antimicrobial agents

      JOURNAL OF CHEMOTHERAPY
    74. Raad, I; Bompart, F; Hachem, R
      Prospective, randomized dose-ranging open phase II pilot study of quinupristin dalfopristin versus vancomycin in the treatment of catheter-related staphylococcal bacteremia

      EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES
    75. Karlowsky, JA; Zhanel, GC; Hoban, DJ
      Vancomycin-resistant enterococci (VRE) colonization of high-risk patients in tertiary care Canadian hospitals

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    76. Chang, SC; Fang, CT; Hsueh, PR; Luh, KT; Hsieh, WC
      In vitro activity of quinupristin/dalfopristin against clinical isolates of common Gram-positive bacteria in Taiwan

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    77. Linden, PK; Miller, CB
      Vancomycin-resistant enterococci: The clinical effect of a common nosocomial pathogen

      DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE
    78. Vasselle, B; Gousset, G; Bounine, JP
      Development and validation of a high-performance liquid chromatographic stability-indicating method for the analysis of Synercid (R) in quality control, stability and compatibility studies

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    79. Moellering, RC; Linden, PK; Reinhardt, J; Blumberg, EA; Bompart, F; Talbot, GH
      The efficacy and safety of quinupristin/dalfopristin for the treatment of infections caused by vancomycin-resistant Enterococcus faecium

      Journal of antimicrobial chemotherapy
    80. Pechere, JC
      Current and future management of infections due to methicillin-resistant staphylococci infections: the role of quinupristin/dalfopristin

      Journal of antimicrobial chemotherapy
    81. Carbon, C
      Costs of treating infections caused by methicillin-resistant staphylococciand vancomycin-resistant enterococci

      Journal of antimicrobial chemotherapy
    82. Schmitz, FJ; Verhoef, J; Fluit, AC
      Prevalence of resistance to MLS antibiotics in 20 European university hospitals participating in the European SENTRY surveillance programme

      Journal of antimicrobial chemotherapy
    83. Khan, AA; Slifer, TR; Araujo, FG; Remington, JS
      Quinupristin-dalfopristin is active against Toxoplasma gondii

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    84. Schlegel, L; Sissia, G; Fremaux, A; Geslin, P
      Diminished killing of pneumococci by pristinamycin demonstrated by time-kill studies

      ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
    85. Houry, D; Crisman, T
      Bivalve polymicrobial infective endocarditis

      SOUTHERN MEDICAL JOURNAL
    86. Lamb, HM; Figgitt, DP; Faulds, D
      Quinupristin/dalfopristin - A review of its use in the management of serious Gram-positive infections

      DRUGS
    87. Lomaestro, BM; Briceland, LL
      Streptogramins and their potential role in geriatric medicine

      DRUGS & AGING
    88. CUPOABBOTT J; HOLTOM P; RHO JP
      FOCUS ON QUINUPRISTIN DALFOPRISTIN - AN INVESTIGATIONAL STREPTOGRAMINANTIBIOTIC FOR THE TREATMENT OF MULTIDRUG-RESISTANT GRAM-POSITIVE INFECTIONS/

      Formulary (Cleveland, Ohio)
    89. LARKIN J; BUSCIGLIO L; FONTANET H; GAMOURAS G
      STAPHYLOCOCCUS-EPIDERMIDIS ENDOCARDITIS TREATED WITH RP-59500 (QUINAPRISTIN DALFOPRISTIN)/

      Clinical infectious diseases
    90. Brooks, AK; Zervos, MJ
      New antimicrobial agents for Gram-positive infections

      CURRENT OPINION IN INFECTIOUS DISEASES
    91. FUCHS P; BARRY A; BROWN S
      PROVISIONAL QUALITY-CONTROL PARAMETERS AND INTERPRETIVE CRITERIA FOR TESTING SUSCEPTIBILITY OF STREPTOCOCCUS-PNEUMONIAE AND HAEMOPHILUS-INFLUENZAE TO QUINUPRISTIN DALFOPRISTIN (RP59500)/

      European journal of clinical microbiology & infectious diseases
    92. ALDRIDGE KE; ASHCRAFT DS; SANDERS CV
      RP-59,500 (QUINUPRISTIN DALFOPRISTIN) - A NEW STREPTOGRAMIN WITH POTENT ACTIVITY AGAINST PENICILLIN-RESISTANT STREPTOCOCCUS-PNEUMONIAE/

      Advances in therapy
    93. JONES RN; BALLOW CH; BIEDENBACH DJ; DEINHART JA; SCHENTAG JJ
      ANTIMICROBIAL ACTIVITY OF QUINUPRISTIN-DALFOPRISTIN (RP-59500, SYNERCID(R)) TESTED AGAINST OVER 28,000 RECENT CLINICAL ISOLATES FROM 200 MEDICAL-CENTERS IN THE UNITED-STATES AND CANADA

      Diagnostic microbiology and infectious disease
    94. HAMMERUM AM; JENSEN LB; AARESTRUP FM
      DETECTION OF THE SATA GENE AND TRANSFERABILITY OF VIRGINIAMYCIN RESISTANCE IN ENTEROCOCCUS-FAECIUM FROM FOOD-ANIMALS

      FEMS microbiology letters
    95. Barry, AL; Fuchs, PC; Brown, SD
      Susceptibility to RPR 106,972, quinupristin/dalfopristin and erythromycin among recent clinical isolates of enterococci, staphylococci and streptococci from North American medical centres

      Journal of antimicrobial chemotherapy
    96. RAHMAN M
      ALTERNATIVES TO VANCOMYCIN IN TREATING METHICILLIN-RESISTANT STAPHYLOCOCCUS-AUREUS INFECTIONS

      Journal of antimicrobial chemotherapy
    97. CASSELL J; BALAKRISHNAN I; SAMARASINGHE D; MISTRY P; PRENTICE HG; GILLESPIE SH
      RP59500 (QUINUPRISTIN DALFOPRISTIN) - 3 CASE-REPORTS OF ITS USE IN INFECTION DUE TO ENTEROCOCCUS-FAECIUM/

      The Journal of infection
    98. LECLERCQ R; COURVALIN P
      STREPTOGRAMINS - AN ANSWER TO ANTIBIOTIC-RESISTANCE IN GRAM-POSITIVE BACTERIA

      Lancet
    99. WAND G; TAYLOR DE
      SITE-SPECIFIC MUTATIONS IN THE 23S RIBOSOMAL-RNA GENE OF HELICOBACTER-PYLORI CONFER 2 TYPES OF RESISTANCE TO MACROLIDE-LINCOSAMIDE-STREPTOGRAMIN-B ANTIBIOTICS

      Antimicrobial agents and chemotherapy
    100. WELTON LA; THAL LA; PERRI MB; DONABEDIAN S; MCMAHON J; CHOW JW; ZERVOS MJ
      ANTIMICROBIAL RESISTANCE IN ENTEROCOCCI ISOLATED FROM TURKEY FLOCKS FED VIRGINIAMYCIN

      Antimicrobial agents and chemotherapy


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 05/08/20 alle ore 13:24:19